About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
Pages
Pages
Home
About
Blog
Blog Post
Contact
Portfolio
Investors
Investor Single
Shop
Shop Single
Utility Pages
Start Here
Style Guide
404 Not Found
Password Protected
Licenses
Changelog
Browse More Templates
Chime Biologics Announces Strategic Collaboration with TNAX Biopharma, Marking Its First Partnership in Japan
Article Date
December 9, 2025
This article is featured on another website.
Go to article
Related posts
Browse all articles
May 11, 2026
Myrtelle to Present Clinical Data and Regulatory Progress for MYR-101 Gene Therapy Program at ASGCT 2026
May 11, 2026
Myrtelle to Present Clinical Data and Regulatory Progress for MYR-101 Gene Therapy Program at ASGCT 2026
July 9, 2026
Beyond the Biomarkers
July 9, 2026
Beyond the Biomarkers